Compare Mutual Funds
Risk
Very High
-
Rating
3.0
-
Min SIP Amount
₹99
-
Expense Ratio
1.94
-
NAV
₹43.04
-
Fund Started
11 Jun 2018
-
Fund Size
₹2753.72 Cr
-
Exit Load
Exit load of 1% if redeemed within 1 year.
-
1 Year
9.03%
-
3 Year
22.30%
-
5 Year
14.21%
-
Equity
99.92%
-
Cash
0.08%
-
Top 10 Holdings
Sun Pharmaceutical Industries Ltd. | 12.20% |
Divi's Laboratories Ltd. | 7.93% |
Glenmark Pharmaceuticals Ltd. | 6.94% |
JB Chemicals & Pharmaceuticals Ltd. | 6.88% |
Apollo Hospitals Enterprise Ltd. | 6.15% |
Lupin Ltd. | 5.06% |
Aurobindo Pharma Ltd. | 4.32% |
Dr. Reddy's Laboratories Ltd. | 4.31% |
Fortis Healthcare Ltd. | 3.73% |
Laurus Labs Ltd. | 3.56% |
-
Name
-
-
Start Date
-
-
Description
The scheme seeks to generate long term capital appreciation through investing in equity and equity related securities of companies benefitting directly or indirectly in Healthcare and allied sectors in India.
-
Launch Date
11 Jun 2018
-
